Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MASLD”

160 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 160 results

Not applicableLooking for participantsNCT06813508
What this trial is testing

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatocellular CarcinomaMetabolic Dysfunction-Associated Steatohepatitis+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Not applicableStudy completedNCT07211113
What this trial is testing

Effects of Long-lasting Bicarbonate-Sulfate-Calcium-Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcome

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
University of Campania Luigi Vanvitelli 87
Not applicableStudy completedNCT05044663
What this trial is testing

Liver and Splenic Stiffness in Predicting Esophageal Varices Needing Treatment in MASLD Related Compensated Advanced Chronic Liver Disease.

Who this might be right for
Chronic Liver Disease
Institute of Liver and Biliary Sciences, India 325
Testing effectiveness (Phase 2)Looking for participantsNCT06588699
What this trial is testing

Digoxin In NASH (CODIN)

Who this might be right for
NASHNAFLDMASH - Metabolic Dysfunction-Associated Steatohepatitis+5 more
Yale University 144
Not applicableNot Yet RecruitingNCT07270822
What this trial is testing

Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes

Who this might be right for
Steatotic Liver DiseaseFibrosis of Liver
Hospices Civils de Lyon 1,714
Not applicableNot Yet RecruitingNCT06453239
What this trial is testing

Assessment the Diagnostic Value of Pro-Neurotensin as a Serum Biomarker in MASLD

Who this might be right for
Steatosis of Liver
Sohag University 80
Not applicableWithdrawnNCT06352177
What this trial is testing

Digital Therapeutic Lifestyle Intervention Program for Patients With MASLD

Who this might be right for
NASHNASH - Nonalcoholic SteatohepatitisLiver Diseases
Milton S. Hershey Medical Center
Post-approval studies (Phase 4)Looking for participantsNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Not applicableNot Yet RecruitingNCT07412444
What this trial is testing

EVOO and Metabolic Liver Health in MASLD

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseOverweight
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 60
Very early researchLooking for participantsNCT07381257
What this trial is testing

Efficacy and Safety of Rifaximin-α in Treating MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Shanghai Changzheng Hospital 60
Not applicableStudy completedNCT05778266
What this trial is testing

Effect of L-citrulline and HIIT on Arterial Stiffness, Body Composition, and Lipid Profile in Adolescents with Steatosis Associated with Metabolic Dysfunction (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Fatty Liver DiseaseObesity, AdolescentArterial Stiffness
Universidad de Guanajuato 43
Not applicableLooking for participantsNCT07270601
What this trial is testing

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD - Non-Alcoholic Fatty Liver Disease
ContextVision AB 110
Not applicableLooking for participantsNCT06867419
What this trial is testing

Metabolic Features Effects on FAST Score in MASLD Patients

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Tanta University 385
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Not applicableLooking for participantsNCT07083336
What this trial is testing

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

Who this might be right for
Type 2 Diabetes MellitusMetabolic Dysfunction-associated Steatotic Liver Disease
State Key Laboratory of Subhealth Intervention Technology 120
Large-scale testing (Phase 3)UnknownNCT06759363
What this trial is testing

MASLD Butyrate Supplementation Treatment Efficacy Review

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
University Medical Center Zvezdara 200
Not applicableStudy completedNCT06688149
What this trial is testing

NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 536
Not applicableEnrolling By InvitationNCT07001865
What this trial is testing

Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolically Healthy ObesityHyperuricemia
Ningbo No. 1 Hospital 17,040
Very early researchNot Yet RecruitingNCT06373523
What this trial is testing

MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin

Who this might be right for
Hepatic Steato-FibrosisNon-Alcoholic Fatty Liver Disease
Post Graduate Institute of Medical Education and Research, Chandigarh 60
Load More Results